SpineUs™
World's first FDA 510(k) cleared AI-powered 3D ultrasound imaging device for spinal care
Company profile
Company profile
Verdure Imaging is a medical imaging technology company that has developed SpineUs™, the world's first FDA 510(k) cleared AI-enabled 3D ultrasound device specifically designed for spinal imaging. The company was founded on a vision to overcome traditional imaging limitations, inspired by the question of why ultrasound couldn't be used to visualize the spine. After years of research and development, Verdure Imaging created a groundbreaking solution that combines 3D ultrasound technology with AI-enabled segmentation to deliver real-time, radiation-free spinal imaging at the point of care. SpineUs™ uses machine learning models trained on paired CT and ultrasound datasets to identify and reconstruct spinal anatomy from ultrasound data, presenting clinicians with clear 3D views immediately after capture. Built on 3D Slicer, the leading open-source platform for medical image computing, the device provides interoperability with native DICOM support and OpenIGTLink real-time streaming. The technology has been validated through clinical research partnerships with academic medical centers, with peer-reviewed studies underway. Verdure Imaging serves healthcare providers, including chiropractors, orthopedic specialists, and spinal care clinics, offering them a compact, portable imaging solution that integrates seamlessly into existing practices. The company's mission centers on empowering medical professionals with innovative tools to enhance diagnostic precision, improve patient outcomes, and make advanced imaging accessible to all by breaking barriers in cost and complexity.
Company description Verdure Imaging official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
On Premise deployment with recorded integration context.
Recorded integration context: 3D Slicer, DICOM, OpenIGTLink.
Company milestones
FDA 510(k) clearance (K241029) for SpineUs™, the world's first FDA-cleared 3D spine ultrasound device. Multi-site clinical validation completed.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
World's first FDA 510(k) cleared AI-powered 3D ultrasound imaging device for spinal care
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
No linked records are currently available.
Clinical validation
No linked records are currently available.
Regulatory
K241029 · 510k · Oct 7, 2024
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Better diagnosis and treatment through accurate spinal alignment measurement
Faster, more accurate diagnostics
Non-invasive, radiation-free imaging alternative
Immediate 3D reconstruction after capture
05 · Leadership
Leadership profiles and professional links from the current Company record.
Chris Schlenger
Founder & CEO
06 · Company updates
Recent articles published on Verdure Imaging's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.